BioNTech (BNTX) Earnings Date, Estimates & Call Transcripts $114.13 +0.62 (+0.55%) (As of 05:19 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BioNTech Latest Earnings SummaryActual EPS (Nov. 4) $0.81 Beat By $2.07 Consensus EPS (Nov. 4) -$1.26 BioNTech announced Q3 2024 earnings on November 4, 2024, reporting an EPS of $0.81, which topped analysts' consensus estimates of -$1.26 by $2.07. Quarterly revenue rose 38.9% year-over-year to $1.24 billion, above the consensus estimate of $514.08 million. With a trailing EPS of -$2.10, BioNTech's earnings are expected to decrease next year, from ($3.72) to ($4.19) per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by Get BioNTech Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioNTech and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBNTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BNTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. BioNTech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$1.02$1.26-$0.08Q2 20243-$1.76-$1.05-$1.35Q3 20243-$1.33$2.98$0.79Q4 20243$0.06$2.76$1.08FY 202412-$4.05$5.95$0.44Q1 20252-$3.42-$1.81-$2.62Q2 20252-$3.50-$2.30-$2.90Q3 20252$0.26$2.20$1.23Q4 20252$0.19$1.85$1.02FY 20258($6.47)($0.06)($3.27) BioNTech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/4/2024Q3 2024-$1.26$0.81+$2.07$0.89$514.08M$1.24B8/5/2024Q2 2024-$2.02-$3.36 -$1.34-$3.62$134.98M$128.70M5/6/2024Q1 2024-$0.82-$1.42 -$0.60-$1.42$589.96M$203.69M3/20/2024Q4 2023$2.64$2.05 -$0.59$2.05$2.04B$1.59B11/6/2023Q3 2023-$0.59$0.67+$1.26$0.73$850.50M$895.30M8/7/2023Q2 2023-$0.83-$0.79+$0.04-$0.86$628.13M$167.70MWall St. Icon: “If you wait on this, it will already be too late” (Ad)If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warning5/8/2023Q1 2023$0.18$2.05+$1.87$2.20$1.09B$1.28B3/27/2023Q4 2022$8.04$9.26+$1.22$9.46$3.87B$4.28B BioNTech Earnings - Frequently Asked Questions When did BioNTech announce their last quarterly earnings? BioNTech (NASDAQ:BNTX) last announced its quarterly earning data on Monday, November 4, 2024. Learn more on BNTX's earnings history. What guidance has BioNTech issued on next quarter's earnings? BioNTech issued an update on its FY 2024 earnings guidance on Monday, November, 4th. The company issued revenue guidance of $2.7 billion-$2.7 billion, compared to the consensus revenue estimate of $2.6 billion. Did BioNTech beat their earnings estimates last quarter? In the previous quarter, BioNTech (NASDAQ:BNTX) reported $0.81 earnings per share (EPS) to beat the analysts' consensus estimate of ($1.26) by $2.07. Learn more on analysts' earnings estimate vs. BNTX's actual earnings. How can I listen to BioNTech's earnings conference call? The conference call for BioNTech's latest earnings report can be listened to online. Listen to Conference Call How can I read BioNTech's conference call transcript? The conference call transcript for BioNTech's latest earnings report can be read online. Read Transcript How much revenue does BioNTech generate each year? BioNTech (NASDAQ:BNTX) has a recorded annual revenue of $3.04 billion. How much profit does BioNTech generate each year? BioNTech (NASDAQ:BNTX) has a recorded net income of $1.01 billion. BNTX has generated -$2.10 earnings per share over the last four quarters. What is BioNTech's EPS forecast for next year? BioNTech's earnings are expected to decrease from ($3.72) per share to ($4.19) per share in the next year. More Earnings Resources from MarketBeat Related Companies GSK Earnings Date TAK Earnings Date TEVA Earnings Date BGNE Earnings Date MRNA Earnings Date VTRS Earnings Date SMMT Earnings Date GMAB Earnings Date RDY Earnings Date CTLT Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Wall St. Icon: “If you wait on this, it will already be too late” (Ad)If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warning This page (NASDAQ:BNTX) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredSix Stocks That Could Soar on Trump’s First Day BackThe recent election results have clarified a path forward, creating opportunities that weren't as clear just m...InvestorPlace | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.